The Guardian News environment reporter Emily Holden received the Endocrine Society’s annual Award for Excellence in Science and Medical Journalism, the Society announced today. Holden is being honored for her coverage of our everyday exposure to harmful chemicals found in plastics, cosmetics and food. The winning article, “Is modern life poisoning me? I took the tests to find out,” was published in The Guardian News in May 2019. This article is part of Toxic America,...
Endocrine Society Announces 2020 Early Investigators Award Winners
The Endocrine Society has selected five recipients for its 2020 Early Investigators Awards. The Early Investigators Awards were established to assist in the development of early-career investigators and to provide greater recognition of their accomplishments in endocrine-related research. The Endocrine Society’s 2020 Early Investigators Award winners are: Mehmet Furkan Burak, MD, of Brigham and Women’s Hospital in Boston, Mass. His research...
Virtual ENDO 2020 News Conferences to Highlight Advances in Technology, Thyroid Health, More
Researchers will discuss how artificial intelligence and drones are being incorporated into health care when they share the latest emerging science during the Endocrine Society’s ENDO 2020 virtual news conferences March 30-31. The press conferences will feature select abstracts that were slated to be presented at ENDO 2020, the Endocrine Society’s annual meeting. The event...
For the first time since World War II, the Endocrine Society has cancelled its annual conference, ENDO 2020, following dire reports regarding COVID-19 from the World Health Organization (WHO), the U.S. Centers for Disease Control (CDC), and local health authorities in San Francisco, the site of the conference. “We have been clear all along that...
Endocrine Society Updates Osteoporosis Clinical Practice Guideline
New recommendations include romosozumab therapy for high risk patients The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture. The U.S. Food and Drug Administration approved romosozumab in April 2019,...